Re: Totect: a new agent for treating anthracycline extravasation.
Ward
Mary S
MS
D018943:Anthracyclines / Q000009:adverse effects*; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D002614:Chelating Agents / Q000627:therapeutic use*; D017277:Drug Approval; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D018579:Patient Selection; D011929:Razoxane / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D002614:Chelating Agents; D011929:Razoxane